A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma
Jorge Luis JImenez-Macias(Brown University), Sean Lawler(Brigham and Women's Hospital)
Cited by 27
Related Papers
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
|Nature Communications|2017|332
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
|Journal of Clinical Investigation|2019|75
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models
|bioRxiv (Cold Spring Harbor Laboratory)|2022|13